Louisiana’s economic future looks good, but not without a stronger workforce improvement, our two guest columnists argue.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kd) syndrome (APDS), a rare primary immunodeficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results